Buscar
Fisiopatología renal y mecanismos farmacológicos de nefroprotección
(Elsevier, 2023-06)
Son varios los factores de riesgo que pueden afectar la progresión de la enfermedad
renal crónica (ERC). La hipertensión arterial, la proteinuria, la obesidad, la hipertensión
intraglomerular, el tabaco y el control ...
Manejo clínico-práctico de los inhibidores del cotransportador sodio-glucosa tipo 2 en pacientes con enfermedad renal crónica
(Elsevier, 2023-06)
El descubrimiento del papel nefroprotector de los fármacos inhibidores del cotransportador
sodio-glucosa tipo 2 (ISGLT2) en las personas con diabetes mellitus tipo 2 (DM 2) tras los
resultados obtenidos en los respectivos ...
Is the Physician’s Behavior in Dyslipidemia Diagnosis in Accordance with Guidelines? Cross-Sectional Escarval Study
(Public Library of Science, 2014)
Background:
Clinical inertia has been defined as mistakes by the physician in starting or intensifying treatment when
indicated. Inertia, therefore, can affect other stages in the healthcare process, like diagnosis. The ...
Dislipidemia y riesgo vascular. Una revisión basada en nuevas evidencias
(Elsevier, 2014-01)
La dislipidemia es uno de los principales factores de riesgo de cardiopatía isquémica, primera causa de mortalidad en el mundo. Realizar una detección temprana y una intervención terapéutica precoz son elementos clave a ...
Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease
(2021-03-25)
Background:
Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent hereditary renal disease. There is an increased rate of cardiovascular disease (CVD) in ADPKD. In this study, we evaluate the prevalence ...
Vitamin D supplementation and Its impact on mortality and cardiovascular outcomes: systematic review and meta-analysis of 80 randomized clinical trials
(MDPI, 2023-04-07)
Background: The impact of vitamin D supplementation on cardiovascular outcomes and mortality risk reduction remains unclear due to conflicting study findings. Methods: We conducted a systematic review and meta-analysis ...
Clinical Experience with Diltiazem in the Treatment of Cardiovascular Diseases
(Springer Verlag (Germany), 2016)
Cardiovascular diseases are the leading cause of death in the world. Coronary artery diseases, atrial fibrillation or hypertensive heart disease, are among the most important cardiovascular disorders. Hypertension represents ...
Erratum to: Clinical Experience with Diltiazem in the Treatment of Cardiovascular Diseases
(Springer Verlag (Germany), 2016)
Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study
(Oxford University Press, 2017)
Background: The ankle-brachial index (ABI) is widely used to
diagnose subclinical peripheral artery disease (PAD) in the general
population, but data assessing its prevalence and related factors
in different chronic ...
Elevated pulse pressure and cardiovascular risk associated in Spanish population attended in primary care: IBERICAN study
(Frontiers Media, 2023)
Introduction: Elevated pulse pressure (ePP) is an independent marker of
cardiovascular risk (CVR) in people older than 60, and a functional marker of
subclinical target organ damage (sTOD) which can predict cardiovascular ...